oversubscribed

Draig Therapeutics Launches with $140 Million (107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of novel, potentially…

2 weeks ago

Max India Limited’s Rights Issue: 1.45 Times Oversubscription Signals Strong Investor Confidence

Max India Limited (MIL) has announced the successful closure of its Rights Issue, raising Rs. 124.23 crore through the issuance…

1 month ago